132 related articles for article (PubMed ID: 9029184)
1. Ether lipids are effective cytotoxic drugs against multidrug-resistant acute leukemia cells and can act by the induction of apoptosis.
Verdonck LF; van Heugten HG
Leuk Res; 1997 Jan; 21(1):37-43. PubMed ID: 9029184
[TBL] [Abstract][Full Text] [Related]
2. Anticancer drug-mediated induction of multidrug resistance-associated genes and protein kinase C isozymes in the T-lymphoblastoid cell line CCRF-CEM and in blasts from patients with acute lymphoblastic leukemias.
Beck JF; Brügger D; Brischwein K; Liu C; Bader P; Niethammer D; Gekeler V
Jpn J Cancer Res; 2001 Aug; 92(8):896-903. PubMed ID: 11509123
[TBL] [Abstract][Full Text] [Related]
3. Multidrug resistance gene (mdr1) RNA levels in relation to P-glycoprotein content of leukemic cells from patients with acute leukemia.
Albertioni F; Gruber A; Areström I; Vitols S
Med Oncol; 1995 Jun; 12(2):79-86. PubMed ID: 8535665
[TBL] [Abstract][Full Text] [Related]
4. Quantitative analysis of a MDR1 transcript for prediction of drug resistance in acute leukemia.
Fujimaki S; Funato T; Harigae H; Fujiwara J; Kameoka J; Meguro K; Kaku M; Sasaki T
Clin Chem; 2002 Jun; 48(6 Pt 1):811-7. PubMed ID: 12028995
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of the Wnt receptor Frizzled-1 (FZD1) reduces MDR1/P-glycoprotein expression in multidrug resistant leukemic cells and inhibits leukemic cell proliferation.
Wang YH; Imai Y; Shiseki M; Tanaka J; Motoji T
Leuk Res; 2018 Apr; 67():99-108. PubMed ID: 29482174
[TBL] [Abstract][Full Text] [Related]
6. Resistance to the new anti-cancer phospholipid ilmofosine (BM 41 440).
Hofmann J; Utz I; Spitaler M; Hofer S; Rybczynska M; Beck WT; Herrmann DB; Grunicke H
Br J Cancer; 1997; 76(7):862-9. PubMed ID: 9328144
[TBL] [Abstract][Full Text] [Related]
7. MRP1 polymorphisms (T2684C, C2007T, C2012T, and C2665T) are not associated with multidrug resistance in leukemic patients.
Mahjoubi F; Akbari S; Montazeri M; Moshyri F
Genet Mol Res; 2008; 7(4):1369-74. PubMed ID: 19065772
[TBL] [Abstract][Full Text] [Related]
8. Lack of elevated drug efflux in adriamycin-resistant immunoblastic B lymphoma cells with mdr1 overexpression.
Chao CC
FEBS Lett; 1995 Oct; 373(3):285-90. PubMed ID: 7589484
[TBL] [Abstract][Full Text] [Related]
9. Flow cytometric monitoring of anthracycline accumulation after anti-neoplastic ether phospholipid treatment.
Principe P; Faussat-Suberville AM; Coulomb H; Marie JP; Braquet P
Anticancer Drugs; 1994 Jun; 5(3):329-35. PubMed ID: 7919458
[TBL] [Abstract][Full Text] [Related]
10. Multidrug resistance (Mdr1) gene expression in peripheral blasts from patients with acute leukemia only rarely increases during disease progression after combination chemotherapy.
Gruber A; Areström I; Albertioni F; Björkholm M; Peterson C; Vitols S
Leuk Lymphoma; 1995 Aug; 18(5-6):435-42. PubMed ID: 8528050
[TBL] [Abstract][Full Text] [Related]
11. Selective killing of malignant cells from leukemic patients by alkyl-lysophospholipid.
Verdonck LF; Witteveen EO; van Heugten HG; Rozemuller E; Rijksen G
Cancer Res; 1990 Jul; 50(13):4020-5. PubMed ID: 2354451
[TBL] [Abstract][Full Text] [Related]
12. Expression of genes related to multiple drug resistance and apoptosis in acute leukemia: response to induction chemotherapy.
Chauhan PS; Bhushan B; Singh LC; Mishra AK; Saluja S; Mittal V; Gupta DK; Kapur S
Exp Mol Pathol; 2012 Feb; 92(1):44-9. PubMed ID: 22037714
[TBL] [Abstract][Full Text] [Related]
13. Multidrug-resistant acute leukemia cells are responsive to prolonged exposure of daunorubicin: implications for liposome-encapsulated daunorubicin.
Verdonck LF; Lokhorst HM; Roovers DJ; van Heugten HG
Leuk Res; 1998 Mar; 22(3):249-56. PubMed ID: 9619916
[TBL] [Abstract][Full Text] [Related]
14. TRAIL decoy receptors mediate resistance of acute myeloid leukemia cells to TRAIL.
Riccioni R; Pasquini L; Mariani G; Saulle E; Rossini A; Diverio D; Pelosi E; Vitale A; Chierichini A; Cedrone M; Foà R; Lo Coco F; Peschle C; Testa U
Haematologica; 2005 May; 90(5):612-24. PubMed ID: 15921376
[TBL] [Abstract][Full Text] [Related]
15. Multidrug resistance in leukemias and its reversal.
Malayeri R; Filipits M; Suchomel RW; Zöchbauer S; Lechner K; Pirker R
Leuk Lymphoma; 1996 Nov; 23(5-6):451-8. PubMed ID: 9031075
[TBL] [Abstract][Full Text] [Related]
16. MDR1 and BCRP1 expression in leukemic progenitors correlates with chemotherapy response in acute myeloid leukemia.
Ho MM; Hogge DE; Ling V
Exp Hematol; 2008 Apr; 36(4):433-42. PubMed ID: 18249061
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxic effects of hexadecylphosphocholine in neoplastic cell lines including drug-resistant sublines in vitro.
Danhauser-Riedl S; Himmelmann A; Steinhauser G; Busch R; Vogler WR; Rastetter J; Berdel WE
J Lipid Mediat; 1990; 2(5):271-80. PubMed ID: 2133272
[TBL] [Abstract][Full Text] [Related]
18. ABCB1 and ABCG2 proteins, their functional activity and gene expression in concert with drug sensitivity of leukemia cells.
Svirnovski AI; Shman TV; Serhiyenka TF; Savitski VP; Smolnikova VV; Fedasenka UU
Hematology; 2009 Aug; 14(4):204-12. PubMed ID: 19635183
[TBL] [Abstract][Full Text] [Related]
19. Dielectrophoretic Microfluidic Chip Enables Single-Cell Measurements for Multidrug Resistance in Heterogeneous Acute Myeloid Leukemia Patient Samples.
Khamenehfar A; Gandhi MK; Chen Y; Hogge DE; Li PC
Anal Chem; 2016 Jun; 88(11):5680-8. PubMed ID: 27149245
[TBL] [Abstract][Full Text] [Related]
20. Predictive value of multidrug resistance proteins and cellular drug resistance in childhood relapsed acute lymphoblastic leukemia.
Styczynski J; Wysocki M; Debski R; Czyzewski K; Kolodziej B; Rafinska B; Kubicka M; Koltan S; Koltan A; Pogorzala M; Kurylak A; Olszewska-Slonina D; Balwierz W; Juraszewska E; Wieczorek M; Olejnik I; Krawczuk-Rybak M; Kuzmicz M; Kowalczyk J; Stefaniak J; Badowska W; Sonta-Jakimczyk D; Szczepanski T; Matysiak M; Malinowska I; Stanczak E; Wachowiak J; Konatkowska B; Gil L; Balcerska A; Maciejka-Kapuscinska L
J Cancer Res Clin Oncol; 2007 Nov; 133(11):875-93. PubMed ID: 17671794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
